CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Serum +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04557371
NCT04557371N/ACompleted
CompareCT.gov

A Clinical Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Cosmetic Facial Skin Care Formulations in Healthy Females With Clinically Assessed Sensitive Skin.

GlaxoSmithKline·interventional·Posted Sep 21, 2020·Updated Apr 22, 2022

In Brief

A clinical study evaluating Serum, Lotion, and 1 other intervention for Skin Care. Completed, enrolled 150 participants across 1 site.

Detailed Summary

This study aims to determine the local cutaneous and ocular tolerance of 3 developmental skin-care products; a serum, a lotion, and a cream in healthy female subjects with clinically evaluated sensitive facial skin for 21 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Care
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 21, 2020
Enrollment StartOct 12, 2020
Primary CompletionDec 22, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.8 years ago

Interventions

Serumother

Participants will topically apply the serum to the face as per normal home use application in place of their current facial serum product.

Lotionother

Participants will topically apply lotion to the face as per normal home use application in place of their current facial lotion product.

Creamother

Participants will topically apply cream to the face as per normal home use application in place of their current facial cream product.